(Q33332528)

English

The comparison of the efficacy and safety of intravenous versus subcutaneous immunoglobulin replacement therapy

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

The comparison of the efficacy and safety of intravenous versus subcutaneous immunoglobulin replacement therapy (English)

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

author name string

Chapel HM

1

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

Spickett GP

2

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

Ericson D

3

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

Engl W

4

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

Eibl MM

5

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

Bjorkander J

6

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

publication date

1 March 2000

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

Journal of Clinical Immunology

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

20

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

94-100

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

Consensus on diagnosis and management of primary antibody deficiencies. Consensus Panel for the Diagnosis and Management of Primary Antibody Deficiencies

1 reference

https://pubmed.ncbi.nlm.nih.gov/10821460

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intravenous immunoglobulin for the prevention of infection in chronic lymphocytic leukemia. A randomized, controlled clinical trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/10821460

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

High-dose versus low-dose intravenous immunoglobulin in hypogammaglobulinaemia and chronic lung disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/10821460

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Subcutaneous infusion of gammaglobulins in management of agammaglobulinaemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/10821460

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Home intravenous immunoglobulin therapy by self-administration

1 reference

https://pubmed.ncbi.nlm.nih.gov/10821460

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intravenous immunoglobulin home treatment for patients with primary immunodeficiency diseases

1 reference

https://pubmed.ncbi.nlm.nih.gov/10821460

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Adverse effects of intravenous immunoglobulin

1 reference

https://pubmed.ncbi.nlm.nih.gov/10821460

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunoglobulin replacement therapy by self-infusion at home

1 reference

https://pubmed.ncbi.nlm.nih.gov/10821460

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Rapid subcutaneous immunoglobulin infusions in children

1 reference

https://pubmed.ncbi.nlm.nih.gov/10821460

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Primary antibody deficiency in adults

1 reference

https://pubmed.ncbi.nlm.nih.gov/10821460

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Home treatment of hypogammaglobulinaemia with subcutaneous gammaglobulin by rapid infusion

1 reference

https://pubmed.ncbi.nlm.nih.gov/10821460

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Slow subcutaneous human intravenous immunoglobulin in the treatment of antibody immunodeficiency: use of an old method with a new product

1 reference

https://pubmed.ncbi.nlm.nih.gov/10821460

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunoglobulin replacement therapy by slow subcutaneous infusion

1 reference

https://pubmed.ncbi.nlm.nih.gov/10821460

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Subcutaneous immunoglobulin replacement in patients with primary antibody deficiencies: safety and costs

1 reference

https://pubmed.ncbi.nlm.nih.gov/10821460

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunoglobulin prophylaxis in patients with antibody deficiency syndromes and anti-IgA antibodies

1 reference

https://pubmed.ncbi.nlm.nih.gov/10821460

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1023/A:1006678312925

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33332528&oldid=2195252075"